Sun Pharma gains after earnings beat estimates

Reuters Market Eye - Sun Pharmaceutical Industries gains 1.6 percent after June-quarter earnings beat estimates on higher U.S. sales.

Sequential rise of 20 percent in U.S. sales is a positive surprise, analysts say.

(Reporting by Abhishek Vishnoi)